On Tuesday, RAPT Therapeutics Inc (NASDAQ: RAPT) was 4.76% up from the session before settling in for the closing price of $1.05. A 52-week range for RAPT has been $0.79 – $10.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -46.08% over the past five years. When this article was written, the company’s average yearly earnings per share was at 39.73%. With a float of $68.90 million, this company’s outstanding shares have now reached $132.01 million.
Let’s look at the performance matrix of the company that is accounted for 131 employees. In terms of profitability, gross margin is 82.19%, operating margin of -2171.96%, and the pretax margin is -2032.75%.
RAPT Therapeutics Inc (RAPT) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward RAPT Therapeutics Inc stocks. The insider ownership of RAPT Therapeutics Inc is 47.81%, while institutional ownership is 45.20%.
RAPT Therapeutics Inc (RAPT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 39.73% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.51% during the next five years compared to -12.39% drop over the previous five years of trading.
RAPT Therapeutics Inc (NASDAQ: RAPT) Trading Performance Indicators
You can see what RAPT Therapeutics Inc (RAPT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.78, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -0.55 in one year’s time.
Technical Analysis of RAPT Therapeutics Inc (RAPT)
RAPT Therapeutics Inc (NASDAQ: RAPT) saw its 5-day average volume 0.52 million, a negative change from its year-to-date volume of 0.85 million. As of the previous 9 days, the stock’s Stochastic %D was 20.89%. Additionally, its Average True Range was 0.10.
During the past 100 days, RAPT Therapeutics Inc’s (RAPT) raw stochastic average was set at 12.28%, which indicates a significant decrease from 26.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.57% in the past 14 days, which was lower than the 170.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2591, while its 200-day Moving Average is $2.1499. Nevertheless, the first resistance level for the watch stands at $1.1500 in the near term. At $1.2000, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.2650. If the price goes on to break the first support level at $1.0350, it is likely to go to the next support level at $0.9700. Assuming the price breaks the second support level, the third support level stands at $0.9200.
RAPT Therapeutics Inc (NASDAQ: RAPT) Key Stats
There are 34,958K outstanding shares of the company, which has a market capitalization of 145.21 million. As of now, sales total 0 K while income totals -116,800 K. Its latest quarter income was 0 K while its last quarter net income were -18,430 K.
